Skip to main content

Table 4 Diagnostic tools used by veterinarians to confirm a suspected case of CanL

From: Management of canine leishmaniosis in endemic SW European regions: a questionnaire-based multinational survey

 

France n = 994

Greece n = 201

Italy n = 231

Technique %

Never

Occasional to frequent

Always

Never

Occasional to frequent

Always

Never

Occasional to frequent

Always

Cytology

Lymph nodes

34.6

52.8

12.6

21.4

58.6

20

46.7

48.0

5.3

Bone Marrow

65.5

30.6

3.9

69.6

29.4

1.1

59.9

33.6

6.6

Skin lesions

65

28.9

6.1

56.6

40.4

3

28.8

56.5

14.7

Serology

IFAT

22.7

28.7

48.6

16

45

39

4.3

48.9

46.8

Rapid tests

42

33.9

24

4.6

37.1

58.3

30.9

38.2

30.9

ELISA

13.5

34.7

51.9

14.3

58.9

26.8

25.2

37.7

37.1

Other techniques

PCR

55.7

36.6

7.7

52.1

46.4

1.4

20.9

66.9

12.2

Protein electrophoresis

42.3

41

16.8

76.6

20.4

2.1

10.6

39.8

49.7

Histopathology

51.1

45.8

3.1

72.3

27.7

0

64.9

35.1

0

Immunohistochemistry

94.3

4.7

1

94.5

5.5

0

83

13.8

3.2

 

Slovenia n = 49

Spain n = 483

Portugal n = 141

Cytology

Lymph nodes

2

4

0

14.3

80.2

5.5

19.4

72.1

8.6

Bone Marrow

2

2

0

18.1

71.4

10.5

36.2

53.2

10.6

Skin lesions

6.1

2

0

34.2

61.8

3.9

82.9

14.6

2.4

Serology

IFAT

0

4

0

6.3

37.9

55.9

9.4

36.7

25.9

Rapid test

0

2

2

11.5

54.0

34.5

20

43.5

36.5

ELISA

0

2

6.1

42.3

47.3

10.4

43.9

43.9

12.2

Other techniques

PCR

0

2

2

8.3

86.6

5.1

57.8

37.6

4.7

Protein electrophoresis

0

2

0

nd

Nd

nd

96.5

1.8

1.8

Histopathology

0

4.1

0

35.3

63.9

0.8

91.5

6.8

1.7

Immunohistochemistry

0

2

0

15.0

40.4

44.6

33.8

48.8

17.5

  1. nd: not determined.